Third Team Member Named to Distinguished PharmaVOICE 100

Wayne, PA, August 22, 2018 – Facet Life Sciences, a leading provider of development software and services for small and growing life sciences teams, today announced that a third team member has been recognized in the PharmaVOICE 100. Sarah DeMare, M.S., a Product Development Champion at Facet, has been named to the 2018 PharmaVOICE 100 for her regulatory leadership.
The 2018 PharmaVOICE 100 celebrates the men and women throughout the life-sciences industry who provide inspiration to their peers, colleagues, and companies through their innovative and motivational approaches to addressing the industry’s myriad challenges. This year marks the third time a Facet Life Sciences member has been recognized in the PharmaVOICE 100 annual list.
Ken VanLuvanee, President and CEO, Facet Life Sciences, commented, “Regulatory leadership is integral to who Facet Life Sciences is and what our clients need from us. Attracting top talent and allowing that talent to do amazing things for our clients is a large reason Facet is growing so rapidly. We are proud to have a third team member included in this distinguished list.”
The PharmaVOICE 100 typically represents a broad cross-section of the industry including a wide range of functional areas and expertise. The 2018 PharmaVOICE 100 appear in the July/August issue of PharmaVOICE. You can view the digital edition here.

About Facet Life Sciences

Facet Life Sciences is the leading provider of innovative development solutions (software and services) designed to help small teams get to and through the FDA©. Our Product Development Champions deliver expert nonclinical, CMC, and clinical regulatory services using cutting-edge technologies that speed product R&D efforts. Facet teams create and manage critical development documentation for some of the industry’s fastest growing, most innovative life sciences companies.